These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16556633)

  • 1. Penetration of didanosine in semen of HIV-1-infected men.
    Cruciani M; Liuzzi G; Chirianni A; Audagnotto S; Bonora S; Di Biagio A; Sinicco A; Bassetti M; Gatti G
    J Antimicrob Chemother; 2006 Jun; 57(6):1244-7. PubMed ID: 16556633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen.
    Lowe SH; van Leeuwen E; Droste JA; van der Veen F; Reiss P; Lange JM; Burger DM; Repping S; Prins JM
    Ther Drug Monit; 2007 Oct; 29(5):566-70. PubMed ID: 17898645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
    Ghosn J; Chaix ML; Peytavin G; Bresson JL; Galimand J; Girard PM; Raffi F; Cohen-Codar I; Delfraissy JF; Rouzioux C
    J Antimicrob Chemother; 2008 Jun; 61(6):1344-7. PubMed ID: 18343806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma.
    Lorello G; la Porte C; Pilon R; Zhang G; Karnauchow T; MacPherson P
    HIV Med; 2009 Oct; 10(9):548-54. PubMed ID: 19515092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration.
    Rosso R; Di Biagio A; Dentone C; Gattinara GC; Martino AM; Viganò A; Merlo M; Giaquinto C; Rampon O; Bassetti M; Gatti G; Viscoli C
    J Antimicrob Chemother; 2006 Jun; 57(6):1168-71. PubMed ID: 16606636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited penetration of lopinavir and ritonavir in the genital tract of men infected with HIV-1 in Brazil.
    Vergara TR; Estrela RC; Suarez-Kurtz G; Schechter M; Cerbino-Neto J; Barroso PF
    Ther Drug Monit; 2006 Apr; 28(2):175-9. PubMed ID: 16628127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HAART with didanosine once versus twice daily: adherence and efficacy.
    Roca B; Lapuebla C; Vidal-Tegedor B
    Int J Infect Dis; 2005 Jul; 9(4):195-200. PubMed ID: 15964537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tenofovir on didanosine absorption in patients with HIV.
    Pecora Fulco P; Kirian MA
    Ann Pharmacother; 2003 Sep; 37(9):1325-8. PubMed ID: 12921517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.
    Wang Y; Livingston E; Patil S; McKinney RE; Bardeguez AD; Gandia J; O'Sullivan MJ; Clax P; Huang S; Unadkat JD
    J Infect Dis; 1999 Nov; 180(5):1536-41. PubMed ID: 10515813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis.
    Chan DJ; Ray JE
    J Pharm Pharmacol; 2007 Nov; 59(11):1451-62. PubMed ID: 17976255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etravirine concentrations in seminal plasma in HIV-infected patients.
    Tiraboschi JM; Niubo J; Ferrer E; Barrera-Castillo G; Rozas N; Maso-Serra M; Podzamczer D
    J Antimicrob Chemother; 2013 Jan; 68(1):184-7. PubMed ID: 22954493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of atazanavir in seminal plasma of men infected with human immunodeficiency virus type 1.
    van Leeuwen E; Ter Heine R; van der Veen F; Repping S; Beijnen JH; Prins JM
    Antimicrob Agents Chemother; 2007 Jan; 51(1):335-7. PubMed ID: 17074793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrations.
    Lowe SH; Wensing AM; Droste JA; ten Kate RW; Jurriaans S; Burger DM; Borleffs JC; Lange JM; Prins JM
    HIV Clin Trials; 2006; 7(6):285-90. PubMed ID: 17197376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amount of seminal IL-1beta positively correlates to HIV-1 load in the semen of infected patients.
    Berlier W; Bourlet T; Lévy R; Lucht F; Pozzetto B; Delézay O
    J Clin Virol; 2006 Jul; 36(3):204-7. PubMed ID: 16730226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.
    Kwara A; Delong A; Rezk N; Hogan J; Burtwell H; Chapman S; Moreira CC; Kurpewski J; Ingersoll J; Caliendo AM; Kashuba A; Cu-Uvin S
    Clin Infect Dis; 2008 Mar; 46(5):719-25. PubMed ID: 18220480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of a once-daily regimen of lopinavir/ritonavir in HIV-1-infected children.
    van der Lee M; Verweel G; de Groot R; Burger D
    Antivir Ther; 2006; 11(4):439-45. PubMed ID: 16856617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children.
    King JR; Nachman S; Yogev R; Hodge J; Aldrovandi G; Damle B; Smith E; Wiznia A; Acosta EP
    Antivir Ther; 2002 Dec; 7(4):267-70. PubMed ID: 12553481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of raltegravir in the semen of HIV-infected men.
    Antoniou T; Loutfy MR; Brunetta J; Smith G; Halpenny R; la Porte C
    Antivir Ther; 2014; 19(6):607-11. PubMed ID: 24518162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.